Zillow Faces CFPB Scrutiny, Amazon Mulls Pharma Play, and SEC Drains Big Law

, The National Law Journal

   | 0 Comments

Escape the daily flood of Trump news dominating the Washington headlines with this roundup of big regulatory developments. Zillow is facing CFPB scrutiny, Amazon mulls a pharmaceuticals play, Democratic state AGs move to defend a key part of Obamacare, and the SEC is boosting its ranks in new hires from Big Law. And here's a story about ducks at the U.S. Capitol.

This premium content is reserved for Legal Times subscribers.

Continue reading by getting started with a subscription.

Already a subscriber? Log in now

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202786696457

Thank you!

This article's comments will be reviewed.